title: Cathepsins B, H, L and cysteine proteinase inhibitors in renal cell carcinoma: no evidence for dysregulated proteolytic balance.
authors.forename: K
authors.initials: K
authors.lastname: Jung
authors.forename: B
authors.initials: B
authors.lastname: Friedrich
authors.forename: I
authors.initials: I
authors.lastname: Türk
authors.forename: J
authors.initials: J
authors.lastname: Roigas
authors.forename: M
authors.initials: M
authors.lastname: Lein
authors.forename: D
authors.initials: D
authors.lastname: Schnorr
authors.forename: S A
authors.initials: SA
authors.lastname: Loening
mesh_terms: D002292:Carcinoma, Renal Cell / Q000201:enzymology*; D002401:Cathepsin B / Q000378:metabolism*; D056655:Cathepsin H; D056668:Cathepsin L; D002403:Cathepsins / Q000378:metabolism*; D003546:Cysteine Endopeptidases / Q000378:metabolism*; D015853:Cysteine Proteinase Inhibitors / Q000378:metabolism*; D010450:Endopeptidases; D004792:Enzyme Precursors / Q000378:metabolism; D006801:Humans; D007680:Kidney Neoplasms / Q000201:enzymology*
chemical_list: D015853:Cysteine Proteinase Inhibitors; D004792:Enzyme Precursors; D002403:Cathepsins; D010450:Endopeptidases; D003546:Cysteine Endopeptidases; D002401:Cathepsin B; C534281:CTSL protein, human; D056668:Cathepsin L; C534126:CTSH protein, human; D056655:Cathepsin H